Panic attacks are common. Panic disorder is more specific. In psychiatry, the diagnosis is not based on one frightening episode alone, but on recurrent panic attacks plus ongoing worry about future attacks and behavior changes related to them. That distinction matters because treatment planning changes when a psychiatrist is treating a full panic disorder pattern rather than isolated panic symptoms. At Advanced Psychiatry Associates, patients across California can be evaluated through Anxiety treatment and ongoing Medication Management, with medication decisions based on diagnosis, severity, safety, prior medication response, and follow-up needs.
Panic Attacks Vs. Panic Disorder: What Psychiatrists Diagnose
A panic attack is a sudden surge of intense fear with physical symptoms such as palpitations, chest discomfort, dizziness, sweating, shaking, or shortness of breath. Panic disorder is the recurring pattern around those attacks: repeated episodes, anticipatory fear, and disruption in daily life. Panic disorder involves frequent, unexpected panic attacks and persistent concern about having more of them. MedlinePlus describes panic treatment as a combination of psychiatric evaluation and medicines such as antidepressants or anti-anxiety medications when indicated. That difference is important because medication for panic attacks is not always the same thing as a long-term panic disorder medication plan.
First-Line Medications: SSRIs and SNRIs
For most adults with panic disorder, psychiatrists usually start with an SSRI or, in some cases, an SNRI. Mayo Clinic states that SSRIs are generally recommended as the first choice of medications for panic disorder because they are usually safer long-term and have a lower risk of serious adverse effects than benzodiazepines. FDA-approved SSRIs for panic disorder include fluoxetine, paroxetine, and sertraline.
What should patients expect early? Usually, there is no instant relief. Antidepressants for panic disorder often take several weeks to show meaningful benefit, and psychiatrists may start at lower doses than they would for depression because some patients with panic disorder are especially sensitive to early activation, jitteriness, GI side effects, or sleep disruption. That early period is exactly where psychiatrist-led Medication Management matters: the goal is not just to pick a drug, but to get through the first weeks safely enough to know whether it will actually help. APA also discusses medication selection more broadly in Why Isn’t Your Medication Working? It Could Be Your Genes, which fits naturally here for patients with prior failed or poorly tolerated medication trials.
Benzodiazepines: Where They Fit And Where They Do Not
Benzodiazepines can reduce panic symptoms quickly. NIMH notes that they can be very effective in rapidly decreasing panic attack symptoms, but also warns that tolerance and dependence can develop, so clinicians may prescribe them only for brief periods of time. Benzodiazepines slow brain and nervous-system activity and carry important risks, especially with longer-term use. That makes them very different from SSRIs and SNRIs.
In practice, psychiatrists may use a benzodiazepine selectively at the start of treatment, during severe short-term escalation, or when a patient is highly symptomatic while waiting for a longer-term antidepressant strategy to start working. But they are usually cautious about turning a short bridge into a permanent plan. This is where benzodiazepines for panic attacks and long-term benzodiazepine risks need to be discussed honestly. They can help quickly, but they are not usually the preferred backbone of long-term panic disorder treatment. APA’s broader article Overpowering Fear: Finding Relief from Panic Attacks is a reasonable related read, but this article stays more narrowly focused on psychiatric medication sequencing.
Medication Side Effects, Interactions, And Safety Issues
Every panic disorder medication plan has tradeoffs. SSRIs and SNRIs may cause nausea, GI upset, headache, insomnia, fatigue, sweating, sexual side effects, or an early sense of activation before symptoms settle down. Benzodiazepines may cause sedation, slowed reaction time, memory effects, and a higher risk when combined with alcohol, opioids, or other sedating substances. NIMH emphasizes that benzodiazepines are most appropriate with caution and close medical oversight because long-term use can lead to tolerance, dependence, and withdrawal-related problems.
For APA patients, this is one reason panic prescribing should stay anchored in Medication Management rather than becoming a loose refill pattern. The medication that looks good on day one is not always the medication that remains safest or most useful over time.
Common Prescribing Pitfalls
Several pitfalls show up again and again in panic prescribing. One is relying too heavily on a benzodiazepine and never building a longer-term plan. Another is mistaking temporary early SSRI side effects for proof that the medication can never work. A third is combining benzodiazepines with alcohol, opioids, or other sedatives, which raises safety risks significantly. NIMH’s medication overview states that long-term benzodiazepine use may lead to tolerance or dependence and that clinicians usually prescribe them for short periods, tapering carefully when needed. MedlinePlus also warns that some benzodiazepines can be habit-forming and should be used exactly as prescribed.
Another pitfall is treating “panic” without confirming whether the larger diagnosis is panic disorder, broader anxiety, depression with panic symptoms, substance-related symptoms, or a medical issue that needs evaluation. APA’s Anxiety treatment fits naturally here because panic symptoms often sit inside a wider anxiety picture that still needs proper psychiatric diagnosis.
Follow-Up Timeline: When Psychiatrists Increase, Switch, Or Combine Medications
Psychiatrists do not judge a panic medication too early or leave it unchanged too long. Early follow-up is usually used to check tolerability, whether panic frequency is changing, whether benzodiazepine use is creeping upward, and whether the antidepressant dose needs to be increased. If the first SSRI is not tolerated or does not help enough after an adequate trial, the plan may shift to a different SSRI or an SNRI. If panic symptoms remain severe, short-term bridging strategies may be reconsidered, but with attention to long-term dependence risk.
When To Seek Urgent Psychiatric Care
Urgent psychiatric evaluation is warranted when panic symptoms are escalating rapidly, medication side effects are severe, sedation is becoming unsafe, substance use is complicating treatment, or suicidal thinking, extreme functional decline, or marked agitation appear. Severe chest pain, fainting, or medically concerning symptoms also need urgent medical evaluation because not every apparent panic episode is purely psychiatric. Panic disorder can be highly treatable, but only when the diagnosis is clear and the medication plan is managed carefully. For patients across California looking for a psychiatrist for panic disorder, APA’s structure of evaluation, plus ongoing medication follow-up, is the right fit for that kind of care.
